8-K: Tradeweb Reports Strong First Quarter 2024 Results Driven by Record Trading Volumes
Quarterly Report
Tradeweb's first quarter 2024 results show significant growth in revenue and trading volume, driven by strong performance across multiple asset classes.
Summary
- Tradeweb reported a strong start to 2024 with first quarter revenues reaching $408.7 million, a 24.1% increase year-over-year, or 23.8% on a constant currency basis.
- The company's average daily volume (ADV) hit a record $1.9 trillion, a 39.1% increase compared to the same period last year.
- Net income for the quarter was $143.4 million, a 40.3% increase year-over-year, while adjusted net income reached $167.9 million, a 30.1% increase.
- Adjusted EBITDA was $219.5 million with a margin of 53.7%, compared to $172.2 million and 52.3% respectively in the prior year period.
- Diluted earnings per share (EPS) was $0.59, and adjusted diluted EPS was $0.71 for the quarter.
- The company declared a quarterly cash dividend of $0.10 per share.
- Tradeweb completed the acquisition of r8fin in January and agreed to acquire ICD in April, expanding its client base and technology offerings.
Sentiment
Score: 9
Explanation: The document presents a very positive outlook with strong financial results, record trading volumes, and strategic acquisitions. The company's performance is significantly better than the prior year period, and management's comments are optimistic about future growth.
Positives
- The company experienced broad-based organic growth across multiple asset classes.
- Record ADV was achieved in several areas, including fully electronic U.S. High Grade credit, U.S. government bonds, European government bonds, and swaps/swaptions.
- The acquisition of r8fin is expected to strengthen Tradeweb's offering with macro hedge funds.
- The acquisition of ICD will add Corporates as a new client channel with significant cross-sell opportunities.
- Tradeweb's free cash flow for the trailing twelve months ended March 31, 2024, was $650.8 million, up 8.5% compared to the prior year period.
- The company has $1.5 billion in cash and cash equivalents and an undrawn $500 million credit facility.
Negatives
- Operating expenses increased by 16.6% to $241.1 million, primarily due to higher employee compensation and benefits.
- Other revenues decreased by 5.4% compared to the prior year period.
- Equities revenue growth was relatively modest at 3.2% compared to other asset classes.
Risks
- The company's future performance is subject to various risks and uncertainties, including market conditions and foreign currency fluctuations.
- The acquisition of ICD is subject to customary closing conditions and regulatory reviews.
- The company's expense guidance assumes an average 2024 Sterling/US$ foreign exchange rate of 1.24, which could impact results if the rate changes significantly.
- The company's GAAP operating expenses and tax rate guidance are not provided due to the inherent difficulty in quantifying certain amounts.
Future Outlook
Tradeweb updated its full-year 2024 guidance, expecting adjusted expenses between $755 and $805 million, trending towards the top end of the range. The company also anticipates $142 million in acquisition and Refinitiv transaction-related depreciation and amortization expense, a non-GAAP tax rate of approximately 24.5% to 25.5%, and cash costs of non-acquisition capital expenditures and capitalized software development between $75 and $83 million. LSEG market data contract revenue is expected to be around $80 million in 2024 and ~$90 million in 2025.
Management Comments
- Billy Hult, CEO of Tradeweb, stated that the company had a very strong start to 2024, continuing last year's momentum.
- He highlighted the 39% increase in quarterly ADV to a record $1.9 trillion.
- Hult also noted the record 17.6% share of U.S. High Grade TRACE, reflecting steady growth in a strategic area.
- He emphasized the importance of innovation and collaboration for Tradeweb's success.
- Hult believes the future of trading is multi-asset class and that innovative technology is how markets will get there.
Industry Context
Tradeweb's strong performance reflects the ongoing trend of increased electronic trading in financial markets. The company's focus on multi-asset class trading and innovative technology aligns with the broader industry shift towards automation and efficiency. The acquisitions of r8fin and ICD demonstrate Tradeweb's strategy to expand its technology offerings and client base, positioning it to compete effectively in the evolving landscape of electronic marketplaces.
Comparison to Industry Standards
- Tradeweb's 39.1% increase in ADV significantly outpaces the overall market growth in electronic trading, suggesting market share gains.
- Competitors like MarketAxess have also seen growth in electronic trading, but Tradeweb's expansion into new asset classes and client segments gives it a competitive edge.
- The 17.6% market share in fully electronic U.S. High Grade TRACE is a strong indicator of Tradeweb's leadership in this segment, compared to other platforms.
- The acquisition of r8fin is similar to moves by other firms to enhance their algorithmic trading capabilities, such as Virtu Financial's acquisition of ITG.
- The ICD acquisition is a strategic move to diversify client base, similar to how other firms are expanding into new markets and client segments.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Board of Directors | Lisa Opoku | First Quarter 2024 | To bring additional finance and legal experience to the Board. |
Stakeholder Impact
- Shareholders will benefit from the strong financial performance and the declared quarterly cash dividend.
- Employees will benefit from increased compensation and benefits tied to the company's financial performance.
- Clients will benefit from the expanded technology offerings and access to new markets.
- The company's growth and acquisitions will likely have a positive impact on suppliers and other business partners.
Next Steps
- The company will continue to integrate r8fin into its platform.
- The acquisition of ICD is expected to close in the second half of 2024.
- Tradeweb will focus on expanding its client base and technology offerings.
- The company will continue to innovate and collaborate to drive future success.
Key Dates
| Date | Description |
|---|---|
| April 8, 2019 | Tradeweb Markets Inc. closed its IPO. |
| April 4, 2019 | Tradeweb Markets Inc. became a holding company. |
| August 31, 2023 | Tradeweb acquired Yieldbroker. |
| November 1, 2023 | LSEG market data contract was amended. |
| January 19, 2024 | Tradeweb completed the acquisition of r8fin. |
| March 31, 2024 | End of the first quarter 2024. |
| April 2024 | Tradeweb agreed to acquire ICD. |
| April 25, 2024 | Date of the earnings release and conference call. |
| June 3, 2024 | Record date for the quarterly cash dividend. |
| June 17, 2024 | Payment date for the quarterly cash dividend. |
Keywords
electronic trading, fixed income, rates, credit, equities, money markets, average daily volume, ADV, financial results, acquisition, technology, market data
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.